Press Digest
Press digest - year 2023
 
The Financial Supervision Commission (FSC) has approved a prospectus for an initial public offering of shares for a capital increase of Sopharma Buildings REIT. The issue is in the amount of up to 3,249,950 ordinary, registered, freely transferable, non-stock voting shares, with a nominal value of BGN 1 and an issue value of BGN 1.86 each. The FSC has entered the issue, which is in the process of being issued, in the register of public companies and other issuers of securities maintained by the FSC.
Source: investor.bg (16.02.2023)
 
Advance Terrafund REIT-Sofia (ATER) Monthly newsletter of Advance Terrafund REIT for January 2023 The newsletter is available in English on the financial website X3News
Source: BSE (16.02.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Following a Board of Directors' decision for an increase in capital of Sopharma Buildings REIT adopted on 22 December 2022 and a subsequent announcement under Art. 89s of the POSA made on 15 February 2023 via the electronic media X3News (www.x3news.com), the website of the issuer (www.sopharma-buildings.com) and of the authorised investment intermediary (www.sis.bg), please, be informed in pursuance of Art. 112b (3) of the POSA, that: - The right to participate in the capital increase is entitled to all shareholders registered with the central securities register not later than five (5) business days after the date of publication of the public offering notice under Art. 89s (1) of the POSA, i.e. by Wednesday, 22 February 2023 (Record Date). - The final date for transacting shares of this company on the Exchange, as a result of which the holder will be entitled to take part in the capital increase, will be Monday, 20 February 2023 (Ex Date: 21 February 2023).
Source: BSE (17.02.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification of the published public offering prospectus regarding the capital increase of Sopharma Buildings REIT
Source: BSE (17.02.2023)
 
Following a Board of Directors' decision for an increase in capital of Sopharma Buildings REIT adopted on 22 December 2022 and a subsequent announcement under Art. 89s of the POSA made on 15 February 2023 via the website of the electronic media x3News (www.x3news.com), please, be informed that the following issue of rights has been admitted to trading on the Subscription Rights Segment of the BSE Main Market by order of the Director of Trading on the grounds of Art. 34 (3) in conjunction with Art. 32 (2) of Part III - Listing Rules of the BSE Rules and Regulations: - Number of shares before the increase: 649,990 - Number of rights issued: 649,990 - Number of shares offered for subscription: 3,249,950 - Nominal value per share: BGN 1.00 - Issue price per share: BGN 1.86 - Ratio between the rights issued and new shares: 1/5 (right/shares) - Everyone may subscribe at least to one (1) new share and at most to the number of shares equal to the number of acquired respectively held rights multiplied by 5. - The capital will be increased if at least 1,624,975 new shares will be subscribed to and paid. - BSE code assigned to the rights issued: SFB1 - ISIN of the rights issued: BG4000003237 - CFI code of the rights issued: To be additionally announced - LEI code of the issuer: 8945008OVC497G1T2P47 - Segment MIC: ZBUL - One trading lot: One (1) right - Currency of trading: BGN - The bid and ask orders are to be entered according to LB1 liquidity band in pursuance of the Annex to Commission Delegated Regulation (EU) 2017/588 of 14 July 2016. - Indicative reference price set for the first trading session: BGN 3.8600 - Starting date of trading in rights on the Exchange: 27 February 2023 - Final date of trading in rights on the Exchange: 10 March 2023 - Starting date of transferring the rights: 27 February 2023 - Final date of transferring the rights: 14 March 2023 - Auction date as per Art. 112b (7) of the POSA: 16 March 2023 - Starting date of subscribing to shares of the increase: 27 February 2023 - Final date of subscribing to shares of the increase: 22 March 2023 - Investment intermediary authorised to administer the capital increase: Sofia International Securities AD - Bank with which an accumulation account will be opened: KBC Bank Bulgaria EAD - The right to participate in the capital increase is entitled to all shareholders registered with the central securities register not later than five (5) business days after the date of publication of the public offering notice under Art. 89s (1) of the POSA, i.e. by Wednesday, 22 February 2023 (Record Date). - The final date for transacting shares of this company on the Exchange, as a result of which the holder will be entitled to take part in the capital increase, has been Monday, 20 February 2023 (Ex Date: 21 February 2023).
Source: BSE (22.02.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT appointed an extraordinary General Meeting of Shareholders on 30 March 2023 at 11:00 am in the city of Sofia at 5 Lachezar Stanchev St. under the following agenda: - Adoption of a justification report of the Board of Directors according to Art. 114a (1) of the POSA on the expedience and terms of a deal under Art. 114 (1), item 1 of the POSA - Authorisation of the Board of Directors to purchase real estate following Art. 114 (1), item 1 of the POSA under the terms detailed in the justification report of the Board of Directors according to Art. 114a (1) of the POSA - In the lack of quorum, the EGM will take place on 20 April 2023 at 11:00 am, same place and agenda. The voting right will be entitled to all shareholders registered with the central securities register fourteen (14) days before the EGM, i.e. by 16 March 2023 (Record Date). The final date for transacting shares of this company on the Exchange, as a result of which the holders will be entitled to exercise their voting right at the EGM, will be 14 March 2023 (Ex Date: 15 March 2023). The invitation is available on the website of the Exchange.
Source: BSE (27.02.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT presented a copy of the publication of the invitation to the extraordinary General Meeting of Shareholders to be held on 30 March 2023 at 11:00 am in the city of Sofia.
Source: BSE (27.02.2023)
 
All unsold rights of "Sopharma Buildings" REIT for the capital increase of the company were traded within the auction, which took place on March 16. 2,205 unsold rights were offered at the auction, against which no shares of the increase were subscribed. The company offered a total of 649,990 rights, each of which gives the right to acquire 5 new shares. The investment intermediary chosen to serve the company's capital increase is "Sofia International Securities" JSC. The company's capital will only be increased if at least 1,624,975 shares are subscribed and paid for, i.e. can be raised between BGN 3.022 million and BGN 6.045 million.
Source: investor.bg (17.03.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT-Sofia publishes the Annual Financial Report for the activities of companies with a special investment purpose - ESEF format as of 12-31-2022.
Source: BSE (21.03.2023)
 
All offered shares from Sopharma Buildings capital increase sold All the offered shares from the capital increase of Sopharma Buildings REIT have been sold. During the subscription period (February 27, 2023 - March 21, 2023), 21 requests to subscribe for shares from the increase were received, of which 4 were from legal entities and 17 from individuals. All 3,249,950 new shares were subscribed and paid for, and their issue value of BGN 6,044,907 was fully paid into the company's collection account. Thus, the company's capital will be increased to almost BGN 6.7 million. Sofia International Securities JSC is an investment intermediary that serves the increase of the company's capital. "Sopharma Buildings" REIT ends 2022 with revenues in the amount of BGN 257 thousand compared to BGN 79 thousand a year earlier, and the profit reaches BGN 179 thousand compared to only BGN 5 thousand in 2021. The increase is determined by a correction of the value of investment properties to BGN 227 thousand at the end of 2022 from BGN 49 thousand at the end of 2021. Rental income is stable at BGN 30 thousand, the same as in 2021
Source: investor.bg (24.03.2023)
 
The capital increase of "Sopharma Buildings" is registered in the Commercial Register. The capital of the company is now in the amount of BGN 3,899,940 after the increase. On March 23, the company announced that it had sold all the offered shares from the capital increase. During the subscription period (February 27, 2023 - March 21, 2023), 21 requests to subscribe for shares from the increase were received, of which 4 were from legal entities and 17 from individuals. The decision to increase the capital of Sopharma Buildings REIT was taken by the board of directors on December 22, 2022. The Financial Supervision Commission (FSC) approved the prospectus for the initial public offering of shares for the increase of the capital of Sopharma Buildings in mid on February. The company offered 3,249,950 ordinary, registered, freely transferable, non-stock voting shares, with a nominal value of BGN 1 and an issue value of BGN 1.86 each.
Source: investor.bg (30.03.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification of the entry in the Commercial Register of the capital increase of Sopharma Buildings REIT
Source: BSE (30.03.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT-Sofia (SFB) announces an Extraordinary General Meeting.
Source: BSE (31.03.2023)
 
Sopharma Buildings REIT-Sofia (SFB) The extraordinary General Meeting of Shareholders of Sopharma Buildings REIT dated 30 March 2023 has passed the following resolutions: - Adoption of a justification report of the Board of Directors according to Art. 114a (1) of the POSA on the expedience and terms of a deal under Art. 114 (1), item 1 of the POSA - Authorisation of the Board of Directors to purchase real estate following Art. 114 (1), item 1 of the POSA under the terms and conditions detailed in the justification report of the Board of Directors according to Art. 114a (1) of the POSA
Source: BSE (03.04.2023)
 
"Sopharma Buildings" buys the base of "Unipharm" in Sofia from "Sopharma" "Sopharma Buildings" REIT buys from "Sopharma" AD a property on "St. Kliment Ohridski" and "Traiko Stanoev" street opposite HTMU, in "Darvenica" district in Sofia. The price of the transaction is BGN 6,337,350, as can be seen from the minutes of the general meeting of shareholders, which took place on March 30. Shareholders have approved the deal. In the same complex was the production and warehouse base of Unifarm, which merged into Sopharma. Sopharma Buildings recently raised capital because of the deal. The capital of the company is now in the amount of BGN 3,899,940 after the increase, after selling all the proposed shares from the increase.
Source: investor.bg (03.04.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification of a decision ¹ 425-E/04.04.2023 of the FSC for registering an issue of shares of 3,249,950 new ordinary registered freely transferable dematerialised and voting shares of BGN 1.00 nominal value per share as a result of the capital increase of Sopharma Buildings REIT from BGN 649,990 to BGN 3,899,940
Source: BSE (05.04.2023)
 
BSE has received an application for admission to trading of a subsequent issue of shares as follows: - Issuer: Sopharma Buildings REIT-Sofia - ISIN of the issue: BG1100084075 - BSE code of the issue: SFB - Amount of the issue before the increase: BGN 649,990 - Amount of the increase: BGN 3,249,950 - Amount of the issue following the increase: BGN 3,899,940 - Number of shares following the increase: 3,899,940 - Nominal value per share: BGN 1.00 /one Bulgarian lev/
Source: BSE (05.04.2023)
 
At a meeting of the Board of Directors of BSE AD under Minutes No. 17/06.04.2023, the following decision was taken: In connection with the Decision of the FSC No. 425 - E of 04.04.2023 regarding the entry of a subsequent issue of shares in the register of public companies and other issuers of securities under Art. 30, para. 1, item 3 of ZKFN, led by KFN, the Board of Directors of BSE AD, on the basis of Art. 33, para. 8, in connection with Art. 19 of Part III Rules for admission to trading, admission to trading of Segment shares on the Alternative Market BàSE subsequent issue of shares, as follows: - Issuer: Sopharma Buildings REIT-Sofia; - ISIN code of the issue: BG1100084075; - Exchange code of the issue: SFB; - Size of the issue before the increase: BGN 649,990; - Amount of the increase: BGN 3,249,950; - Amount of the issue after the increase: BGN 3,899,940; - Number of shares after the increase: 3,899,940 shares; - Nominal value of one share: BGN 1.00 (one). - Type of shares: ordinary, registered, non-present with voting rights; - Date of introduction for trading: 11.04.2023 (Tuesday).
Source: BSE (07.04.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification of the decision of the BSE Board of Directors to admit to trading on the Exchange a subsequent issue of shares following the capital increase of Sopharma Buildings REIT
Source: BSE (10.04.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification under Art. 112e of the POSA of a change to Sopharma Buildings REIT capital in March 2023
Source: BSE (19.04.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT-Sofia presented a quarterly report for the First Quarter of 2023.
Source: BSE (02.05.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT presented a copy of the publication of the invitation to the regular General Meeting of Shareholders to be held on 09 June 2023 at 2:00 pm in the city of Sofia.
Source: BSE (04.05.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT-Sofia (SFB) convenes a regular AGM on 06/09/2023 at 2:00 p.m. in the city of Sofia, 5 Lachezar Stanchev St., Sopharma Business Towers, Building A, floor 20, with the following agenda: - Report of the management bodies on the company's activities in 2022; - Adoption of the company's annual financial report for 2022; - Report of the registered auditor for 2022; - Report of the Audit Committee for 2022; - Report of the Director of Investor Relations for 2022; - Acceptance of a report on the implementation of the Policy on the remuneration of the members of the governing bodies; - Release of the members of the governing bodies from responsibility for their activities in 2022; - Election of a registered auditor for 2023; - Re-electing the members of the Audit Committee for a new mandate and determining their remuneration; - Changes in the company's statutes; - Decision on distribution of financial result. Draft decision: No dividend for 2022. The generated profit for 2022, in the amount of BGN 178,515.42, to be transferred to the Reserve fund; - Determining the amount of remuneration of the members of the governing bodies. - In the absence of a quorum, the meeting will be held on 26.06.2023 at 2 p.m. at the same place and with the same agenda. The right to vote in the General Meeting of Shareholders is exercised by the persons registered as such with the right to vote in the central register of securities 14 days before the date of the General Meeting of Shareholders, or as of 26.05.2023. The last date for concluding transactions with shares of this company on the Stock Exchange, as a result of which the acquirer will be able to exercise the right to vote in the General Meeting of Shareholders, is 23.05.2023.
Source: BSE (04.05.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification of the regular General Meeting of Shareholders held on 09 June 2023
Source: BSE (13.06.2023)
 
Sopharma Buildings REIT-Sofia (SFB) The regular General Meeting of Shareholders of Sopharma Buildings REIT dated 09 June 2023 passed the following resolutions: - Adoption of the 2022 activity report of the managing bodies - Adoption of the 2022 annual financial report of the company - Adoption of the report of the registered auditor on the verification of the 2022 annual financial report - Adoption of the report of the Audit Committee on 2022 - Adoption of the report of the Investor Relations Director on 2022 - Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies - Release from liability of the members of the managing bodies for their activity in 2022 - Election of a registered auditor for 2023 - Re-election of the members of the Audit Committee for a new term of office and fixing their remuneration - Amendments to the Statutes of the company - No dividend distribution for 2022 and allocation of the 2022 profit of BGN 178,515.42 to the company's reserves - Determination of the remuneration to the members of the managing bodies
Source: BSE (14.06.2023)
 
Sopharma Buildings REIT-Sofia (SFB) The company disclosed information regarding a deal under Art. 114 (1), item 1 of the POSA.
Source: BSE (15.06.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT publishes a notification under Art. 114, para. 1, item 1 of the POSA.
Source: BSE (16.06.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification regarding registered changes in the company's articles of association.
Source: BSE (23.06.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT-Sofia presented a quarterly report for the Second Quarter of 2023.
Source: BSE (31.07.2023)
 
"Sopharma Buildings" will build a residential complex opposite the Technical University in Sofia "Sopharma Buildings" plans to build a residential complex on the site of the former buildings of the Scientific Research Chemical and Pharmaceutical Institute (NIHFI) and "Unipharm", which are located opposite the Technical University in Sofia and not far from the office towers of "Sopharma". "Sopharma Buildings" has revenues of less than BGN 1 million. At the beginning of this year, however, its capital was increased, and at the end of March it bought from "Sopharma" the land of its former subdivisions - NIHFI and "Unifarm" for 6.337 million without VAT. The assessment states that the land has a total area of 17,688 sq.m., and a maximum building height of 20m and a density of less than 60% is permitted in the area. Since a key infrastructure passes through the land in "Darvenica", near Studentski Grad, it is not possible to use the entire area for construction. "Sopharma Buildings" will directly sell the built apartments in the complex, and will not rent them out. Since the decision to purchase the land, the price of the company's shares has more than doubled and reached BGN 17.60. The revenues of "Sopharma" for the half year increased by 13.4% compared to the same period last year and reached BGN 125 million. BGN, and the net profit for the period jumped by 57.2% to BGN 37.1 million. Last year was also extremely good for the pharmaceutical company. It ended with a profit of nearly BGN 40 million, which was fully distributed as a dividend of 60 cents per share.
Source: Dnevnik (08.08.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification of a decision of the Board of Directors of Sopharma Buildings REIT on a specific order assignment pursuant to an annex concluded to the existing agreement for performance of activities as a third party under Art. 27 (4) of the SPICCSA
Source: BSE (08.08.2023)
 
FSC approved the project for a residential complex in the former base of "Unifarm" The Financial Supervision Commission (FSC) has approved the design and construction contract between "Sopharma Buildings" REIT and "Telekomplekt" AD, which complements the contract between the two companies for carrying out activities as a service company of "Telekomplekt" from September 2007. With approvals a contract has been awarded for the engineering for the construction of the site of the former production and warehouse base of "Unifarm" in the "Darvenitsa" district in Sofia. Sopharma Buildings acquired the property, located at 3 Kliment Ohridski Blvd., from Sopharma in the spring. Sopharma Buildings increased its capital for the transaction. The old buildings were demolished and the grounds were cleared in April-May this year. "Sopharma Buildings" announced at the beginning of the week that a residential complex with garages and serving commercial areas will be built on the site. The total built-up area is expected to be around 45 thousand sq.m. The estimated value of the investment in the complex is EUR 30 million without VAT.
Source: investor.bg (14.08.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Notification that the Financial Supervision Commission approved a design and construction agreement signed between Sopharma Buildings REIT and Telecomplect AD on 07 August 2023 for amending and supplementing the service agreement signed by both parties on 14 September 2007 and assigning the engineering of a construction on a site owned by Sopharma Buildings REIT
Source: BSE (14.08.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Corrected share participation disclosure notification under Art. 148b of the POSA.
Source: BSE (07.09.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Share participation disclosure notification under Art. 148b of the POSA.
Source: BSE (07.09.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Share participation disclosure notification under Art. 148b of the POSA.
Source: BSE (08.09.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Share participation disclosure notification
Source: BSE (11.09.2023)
 
At a meeting of the Committee on Indices at BSE AD, according to Protocol No. 8 of 11.09.2023, the following decisions were taken: III. In connection with item 8 of Appendix No. 3 (Calculation Methodology of BG REIT) to the Rules for Calculation of Indices of the Bulgarian Stock Exchange, the Commission on Indices determines the following free-float coefficients of the issues included in the base of BG REIT, which will enter into force as of 18.09.2023: Stock code Issuer Free-float coefficient ATER Advance Terafund REIT-Sofia 0.6112 BSP Balkan & Sea Properties REIT-Varna 0.3954 RPF Roy Property Fund REIT-Sofia 0.3843 SFB Sopharma Buildings REIT-Sofia 0.3003 SBPF Super Borovets Property Fund REIT-Burgas 0.6458 BREF Real Estate Fund Bulgaria REIT-Sofia 0.7429 CCBR CCB Real Estate Fund REIT-Sofia 0.5093 The free-float data of BG REIT's issues is a median value for the period from 02.06.2023 to 01.09.2023. IV. In relation to item 15 of the Rules for calculating the index of companies with good corporate governance CGIX, the Indices Commission determines the following free-float coefficients of the issues included in the CGIX base, which will come into force as of 18.09.2023 year: Stock code Issuer Free-float coefficient ALB Albena AD-k.c. Albena 0.2993 BSE Bulgarian Stock Exchange AD-Sofia 0.4995 IHB Industrial Holding Bulgaria AD-Sofia 0.2198 KBG Corrado-Bulgaria AD-Strazitsa 0.1785 MONB Monbat AD-Sofia 0.1733 SFA Sopharma AD-Sofia 0.2885 CHIM Chimimport AD-Sofia 0.2210 Data on free-float issues from CGIX are as of 09/01/2023. V. In relation to item 20 of the Rules for calculating an index of companies on the beam (beamX) market, the Indices Commission determines the following free-float coefficients for the issues included in the beamX base, which will come into force as of 18.09 .2023: Stock code Issuer Free-float coefficient AMON AmonRa Energy AD-Sofia 0.0482 BEE BEE Smart Technologies AD-Sofia 0.2596 BDT Biodit AD-Sofia 0.1741 DRON Dronamix Capital AD-Sofia 0.9165 HRC HR Capital AD-Sofia 0.1805 IMP Impuls I AD-Sofia 0.8557 MFG MFG Invest AD-Sofia 0.1107 SIN Sin Cars Industry AD-Sofia 0.1228 SO Smart Organic AD-Sofia 0.0365 WIN Webit Investment Network AD-Varna 0.8546 Free-float emission data from beamX is a median value for the period 06/02/2023 to 09/01/2023. VI. The Commission on Indices will determine the weight coefficients of the issues included in the bases of the BSE indices (including in the index of companies on the beam market) and the CGIX index based on the respective "close" prices as of 09/15/2023. VII. The next meeting of the Indices Commission, at which the free-float coefficients of the issues included in the BSE indices (including the beam market companies index) and the CGIX index will be determined, will be held on 04.12.2023 y., and these coefficients will come into force starting from 18.12.2023.
Source: BSE (12.09.2023)
 
At a meeting held by the Board of Directors of the BSE under Protocol No. 49 of 11.09.2023, the following decisions were taken: II. Revision based on BGBX 40 Pursuant to Art. 15, item 4 of the BSE Index Calculation Rules in connection with item 15 of Appendix No. 2 (Methodology for BGBX 40 calculation), the Board of Directors excludes the following six issues of shares from the base of the BGBX 40 index: THQM Chaikapharma High-quality medicines AD-Sofia; SFI Sofarma properties REIT-Sofia; FZLS Phaserless AD-Silistra; ELHM Elhim Iskra AD-Pazardzhik; BSP Balkan and Sea Properties REIT-Varna; and BRP Shipping Bulgarian River Navigation AD-Ruse; and adds the following six share issues to the base of the BGBX 40 index: BPF Bravo Property Fund REIT-Sofia; T57 Trace Group Hold AD-Sofia; GTH Investment Company Galata AD-Varna; HNVK Holding Nov Vek AD-Sofia; HRZ Rodna Zemya Holding AD-Sofia; and HIKA Industrial Capital Holding AD-Sofia. III. Basis Revision of BG REIT Pursuant to Art. 15, item 4 of the BSE Index Calculation Rules in connection with item 12 of Appendix No. 3 (Calculation Methodology of BG REIT), the Board of Directors excludes the following issue of shares from the base of the BG REIT index: ICPD Intercapital Property Development REIT-Sofia; and adds the following issue of shares to the base of the BG REIT index: SFB Sopharma Buildings REIT-Sofia. IV. Revision based on BG TR30 Pursuant to Art. 15, item 4 of the Rules for calculating BSE indices in connection with item 17 of Appendix No. 4 (Methodology for calculating BG TR30), the Board of Directors excludes the following four share issues from the basis of the BG TR30 index: SFI Sopharma Real Estate REIT-Sofia, MONB Monbat AD-Sofia, FIB TB First Investment Bank AD-Sofia, i ALB Albena AD-k.c. Albena; and adds the following four share issues to the base of the BG TR30 index: TBS Telelink Business Services Group AD-Sofia, HNVK Holding Nov Vek AD-Sofia, CHSB Himsnab Bulgaria AD-Sofia, i HSOF Holding Sveta Sofia AD-Sofia. Decisions to change the base of the BGBX 40, BG REIT and BG TR30 indices shall come into force as of the first trading session after the third Friday of the month in which the relevant meeting was held, or in the specific case of September 18, 2023.
Source: BSE (12.09.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Share participation disclosure notification
Source: BSE (14.09.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Share participation disclosure notification
Source: BSE (29.09.2023)
 
Sopharma Buildings REIT-Sofia (SFB) Sopharma Buildings REIT-Sofia presented a quarterly report for the Third Quarter of 2023.
Source: BSE (31.10.2023)
 
At a meeting held by the Committee on Indices at BSE AD, according to Protocol No. 10 of 04.12.2023, the following decisions were taken: III. In connection with item 8 of Appendix No. 3 (Calculation Methodology of BG REIT) to the Rules for Calculation of Indices of the Bulgarian Stock Exchange, the Commission on Indices determines the following free-float coefficients of the issues included in the base of BG REIT, which will enter into force as of 18.12.2023: Stock code Issuer Free-float coefficient ATER Advance Terafund REIT-Sofia 0.6106 BSP Balkan & Sea Properties REIT-Varna 0.3958 RPF Roy Property Fund REIT-Sofia 0.4467 SFB Sopharma Buildings REIT-Sofia 0.2723 SBPF Super Borovets Property Fund REIT-Burgas 0.6570 BREF Real Estate Fund Bulgaria REIT-Sofia 0.7429 CCBR CCB Real Estate Fund REIT-Sofia 0.5094 The free-float data of BG REIT's issues is a median value for the period from 02.09.2023 to 01.12.2023. IV. In relation to item 15 of the Rules for calculating the index of companies with good corporate governance CGIX, the Indices Commission determines the following free-float coefficients of the issues included in the CGIX base, which will come into force as of 18.12.2023 year: Stock code Issuer Free-float coefficient ALB Albena AD-k.c. Albena 0.2993 BSE Bulgarian Stock Exchange AD-Sofia 0.4995 IHB Industrial Holding Bulgaria AD-Sofia 0.2195 KBG Corrado-Bulgaria AD-Strazitsa 0.1785 MONB Monbat AD-Sofia 0.1732 SFA Sopharma AD-Sofia 0.2910 CHIM Chemimport AD-Sofia 0.2149 Data on free-float issues from CGIX are as of 01.12.2023. V. In relation to item 20 of the Rules for calculating an index of companies on the beam (beamX) market, the Commission on Indices determines the following free-float coefficients for the issues included in the beamX base, which will come into force as of 18.12 .2023: Stock code Issuer Free-float coefficient AMON AmonRa Energy AD-Sofia 0.0379 BEE BEE Smart Technologies AD-Sofia 0.2594 BDT Biodit AD-Sofia 0.1741 DRON Dronamix Capital AD-Sofia 0.9135 HRC HR Capital AD-Sofia 0.1805 IMP Impuls I AD-Sofia 0.8472 MFG MFG Invest AD-Sofia 0.1107 SIN Sin Cars Industry AD-Sofia 0.1228 SO Smart Organic AD-Sofia 0.0365 WIN Webit Investment Network AD-Varna 0.8546 Free-float emission data from beamX is a median value for the period 09/02/2023 to 12/01/2023. VI. The Commission on Indices will determine the weighting coefficients of the issues included in the bases of the BSE indices and the CGIX index, based on the respective "close" prices as of 15.12.2023. VII. The next meeting of the Indices Commission, at which the free-float coefficients of the issues included in the BSE indices and in the CGIX index will be determined, will be held on 03/04/2024, and these coefficients will come into force as of 03/18 .2024
Source: BSE (05.12.2023)